Abstract
INTRODUCTION
Neuropilin-1 (Nrp1) is a type I transmembrane protein with multiple domains that functions as a co-receptor for growth factor beta (TGF). The molecule itself lacks kinase activity, but it associates with other receptors such 45 as integrins, plexins and VEGF receptor, that mediate transmembrane signaling 1 . It was first studied in the 46 nervous system, where neuropilin-1 is known to participate in neuronal development and provide cues for axonal guidance 2 . Later the interaction between VEGF and Nrp1 was found to play an important role in 48 angiogenesis 3, 4 . The involvement of Nrp1 in the growth of new blood vessels in tumor vasculature promotes 49 tumor progression, and its blockade can restrict tumor growth 5, 6 . Nrp1 can also be expressed by tumor cells 50 themselves, and a peptide which inhibits VEGF-Nrp1 interactions has been shown to induce a apoptosis of 
57
Expression of Nrp1 differentiates natural from inducible regulatory T cells in some physiological settings 9,10 ,
58
and also identifies CD4 + C25 -T cells with inhibitory function and the ability to recruit conventional T reg
11
.
59
Interestingly a recent report showed Nrp1 expression on group 3 innate lymphoid cells (ILC3s) in the lung with rapidly to re-infection. Memory cells develop from memory precursors present early in the T cell response Single-cell suspensions from spleen were prepared by passing them through cell strainers, and resuspended suspensions were then filtered through a 70 µm nylon cell strainer (BD Biosciences), washed, and resuspended in PBS with 2% bovine growth serum (BGS) and APC-conjugated tetramer specific for the MHV-
19
68 dominant epitope (ORF61, NIH tetramer core facility) at room temperature for 1 hour, followed by 10 µg/ml 
RESULTS

35
Nrp1 is upregulated with both persistent and non-persistent MHV-68 infection
36
Our previous research has shown the CD8 T cell response differs between infection with a mutant MHV-68
37
with a deletion in ORF73 (FS73) 15, 16 , which is essential for latent infection, when compared with a revertant
38
virus that retains the ability to persist in the host. In order to understand the role of Nrp1 on CD8 T cells upon
39
MHV-68 infection, we initially measured the kinetics of Nrp1 expression on CD8 T cells after either persistent
40
(FS73R) or non-persistent (FS73) MHV-68 infection. Mice were infected with the relevant virus, then at various the frequency of CD8 T cells recognizing the dominant epitope 17 (Fig. 1A and B) . Consistent with our previous studies 16 , the magnitude of the CD8 T cell response was greater in the FS73R infected mice during the first on d14, when CD8 T cell responses peak in MHV-68 infection 16, 17 (Fig. 1C) . Nrp-1 expression slowly declined after 14 days, and had reduced to baseline expression levels by 60 days post-infection. While Nrp-1 was
48
induced with these kinetics in both FS73 and FS73R infection, the induction was significantly greater after
49
FS73 infection from days 14-21 post infection, but not significantly different thereafter ( Fig. 1C and D 
53
These data indicate the absence of persistent infection leads to a greater induction of Nrp1 in the responding
54
CD8 T cell population. 
78
Effect on the CD8 T cell responses of Nrp1 deletion
79
To test the effect of Nrp1 on CD8 T cell differentiation during murine gammaherpesvirus infection, we treated
80
Nrp1 mice with tamoxifen as described above, and infected them with FS73 or FS73R two days after the last absence of Nrp-1 does not affect this phenotype. These data showed Nrp1 favored the differentiation of effector CD8 T cells during the peak response, and in it's absence T cells differentiated preferentially toward the memory precursor phenotype. However these changes did not endure to the memory phase, where both
Having observed a role for Nrp1 in the formation of memory CD8 T cells during the effector response, we next
04
tested whether the quality of the resulting memory population was altered by re-challenging with virus. As in 05 previous experiments, tamoxifen was administered before infection to delete Nrp1, then splenic CD8 T cells
06
were purified on d28 post-infection, and adoptively transferred into congenic recipient mice (Fig. 5A ). YFP 
12
In the previous experiment Nrp1 was absent both during the primary CD8 T cell response, where 13 memory 'programming' occurs, and also after CD8 T cells differentiated into memory cells. Next we tested 14 whether the absence of Nrp1 during the secondary response alone affected T cell expansion. To examine this,
15
we performed a similar experiment, but this time tamoxifen treatment started at d28 post-infection, then 16 spleens were harvested two days after the cessation of treatment (Fig. 6A ). As before, purified CD8 T cells 
48
Other evidence for these cells being in a different state of differentiation relative to memory cells in non-
49
persistently infected animals includes lower levels of Bcl-2, lower IL-2 production and a faster turnover 16 .
50
Maintaining memory CD8 T cells in this differentiation state may be more dependent on Nrp1, which may also
51
have an impact on their ability to mount a recall response.
Our data show that, regardless of virus strain, the absence of Nrp1 on CD8 
77
To interrogate the function of Nrp-1 during the recall response itself, we allowed the effector and memory
78
response to develop in the presence of Nrp1 then deleted it just prior to memory cell harvest and cell transfer 79 to secondary recipients. In this context deletion of Nrp1 enhanced the recall response, by promoting T cell to repress CD8 T cell proliferation and limit cell survival, presumably to limit the size of the T cell response and prevent immunopathology during the recall response. synapse. This is not a concern in our studies, as we used genetic deletion to ablate Nrp1 expression.
94
Our finding that Nrp1 expressed during the secondary response represses the proliferative response can be 
02
Percentages shown are among the total CD8 or CD4 population, as appropriate. 
